Summary
JWA (AF070523) was originally identified as a novel all-trans retinoic acid (ATRA) responsible gene in primary human tracheal bronchial epithelial cells. For the notable performance achieved by ATRA in the differentiation induction therapy, we investigated the role of JWA in ATRA-mediated differentiation of the human myeloid leukemia HL-60 cells. We found that concomitant with the progressive cell differentiation, JWA expression was up-regulated by ATRA in a dose- and time-dependent manner. Inhibition of JWA expression by RNA interference partially blocked ATRA-induced differentiation and growth inhibition of HL-60 cells. Pre-treatment of phorbol-12-myristate-13-acetate (TPA), a PKC activator, decreased ATRA-mediated differentiation, companied with the down-regulation of JWA expression. Arsenic trioxide (As2O3, 0.5 \(\upmu\)M) enhanced the cellular differentiation induced by 0.01 \(\upmu\)M ATRA, but had no noticeable effect on the differentiation induced by 0.1 \(\upmu\)M ATRA. Concurrent with the enhancement, JWA expression was up-regulated. All the data suggest that up-regulation of JWA expression is essential for ATRA-induced differentiation of HL-60 cells. And JWA, associated with PKC, is involved in its signal pathways. Ideal therapeutic efficacy with low toxicity may be obtained if low doses of ATRA (0.01 \(\upmu\)M) and As2O3 (0.5 \(\upmu \)M) are combined. These findings may present a novel mechanism that cellular differentiation and growth inhibition induced by ATRA are mediated at least in part through regulation of JWA expression. JWA may be a novel molecular marker for ATRA-induced HL-60 cell differentiation. ATRA up-regulates JWA expression by stimulating the transcriptional activity of JWA gene promoter.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Zauli G., Visani G., Bassini A., Caramelli E., Ottaviani E., Bertolaso L., Bertagnolo V., Borgatti P., Capitani S. (1996) Nuclear translocation of protein kinase C-alpha and -zeta isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid. Br. J. Haematol. 93: 542–550
Tallman M.S., Nabhan C., Feusner J.H., Rowe J.M. (2002) Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 99: 759–767
Idres N., Benoit G., Flexor M.A., Lanotte M., Chabot G.G. (2001) Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Cancer Res. 6: 700–705
Launay S., Gianni M., Diomede L., Machesky L.M., Enouf J., Papp B. (2003) Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RAR \(\alpha\) and calcium-dependent signaling. Blood 101: 3220–3228
Chambon P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940–954
Zhou J.W., Di Y.P. and Zhao Y.H. A novel cytoskeleton associate gene-cloning, identification, sequencing, regulation of expression and tissue distribution of JWA. In: Ye X.S., Shen B.F. and Tang X.F. (Eds), Investigation on Cell Modulation: Signal Transduction, Apoptosis and Gene Expression. Beijing, 1999, pp. 110–119
Lin C.I., Orlov I., Ruggiero A.M., Dykes-Hoberg M., Lee A., Jackson M., Rothstein J.D. (2001) Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature 410: 84–88
Butchbach M.E., Lai L., Lin C.L. (2002) Molecular cloning, gene structure, expression profile and functional characterization of the mouse glutamate transporter (EAAT3) interacting protein GTRAP3-18. Gene 292: 81–90
Butchbach M.E., Guo H., Lin C.L. (2003) Methyl-beta-cyclodextrin but not retinoic acid reduces EAAT3-mediated glutamate uptake and increases GTRAP3-18 expression. J. Neurochem. 84: 891–894
Schweneker M., Bachmann A.S., Moelling K. (2005) JM4 is a four-transmembrane protein binding to the CCR5 receptor. FEBS Lett. 579: 1751–1758
Ingley E., Williams J.H., Walker C.E., Tsai S., Colley S., Sayer M.S., Tilbrook P.A., Sarna M., Beaumont J.G., Klinken S.P. (1999) A novel ADP-ribosylation like factor (ARL-6), interacts with the protein-conducting channel SEC61beta subunit. FEBS Lett. 459: 69–74
Matsuda A., Suzuki Y., Honda G., Muramatsu S., Matsuzaki O., Nagano Y., Doi T., Shimotohno K., Harada T., Nishida E., Hayashi H., Sugano S. (2003) Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22: 3307–3318
Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., Der C.J. (1998) Increasing complexity of Ras signaling. Oncogene 17: 1395–1413
Bar-Sagi D., Hall A. (2000) Ras and Rho GTPases: a family reunion. Cell 103: 227–238
Kyriakis J.M., Avruch J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81: 807–869
Shen Q., Zhou J.W., Shen R.L., Lu H., Cao H.X., Xia W. (2001). The significance of expression of JWA gene in acute non-lymphocytic leukemia. Acta Nanjing Med. Univ. 21:406–407. (in Chinese)
Shen Q., Zhou J.W., Shen R.L., Lu H., Cao H.X., Xia W. (2001). To detect the expression of JWA gene by semi-quantity RT-PCR in chronic myelogenous leukemia. Jiangsu Med. J. 27:1–3; (in Chinese)
Xia W., Zhou J.W., Cao H.X. (2001) The relationship between structure and function of JWA in the modulation of cell differentiation. Chinese Sci. Bull. 46:2063–2067
Cao H.X., Xia W., Zhou J.W. (2002) The role of JWA in acute promyelocytic leukemia cell differentiation and apoptosis triggered by retinoic acid, 12-tetradecanoylphorbol-13-acetate and arsenic trioxide. Chinese Sci. Bull. 47:834–838
Savickiene J., Gineitis A., Stigbrand T. (1999) Modulation of apoptosis of proliferating and differentiating HL-60 cells by protein kinase inhibitors: suppression of PKC or PKA differently affects cell differentiation and apoptosis. Cell Death Differ 6:698–709
Paquette R.L., Koeffler H.P. (1992) Differentiation therapy. Hematol. Oncol. Clin. N. Am. 6: 687–706
Scott R.E. (1995) The differentiation therapy of cancer: past, present, and future. Mol. Cell Differ 3: 157–173
Chou T.C., Talalay P. (1984) Quantitative analysis of dose effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22: 27–55
Berenbaum M.C. (1981) Criteria for analyzing interactions between biologically active agents. Cancer Res. 35: 269–335
Fontana J.A., Reppucci A., Durham J.P., Miranda D. (1986) Correlation between the induction of leukemic cell differentiation by various retinoids and modulation of protein kinases. Cancer Res. 46:2468–2473
Carter C.A., Parham G.P., Chambers T. (1998) Cytoskeletal reorganization induced by retinoic acid treatment of human endometrial adenocarcinoma (RL95-2) cells is correlated with alterations in protein kinase C-alpha. Pathobiology 66:284–292
Newton A.C. (1997) Regulation of protein kinase C. Curr. Opin. Cell Biol. 9: 161–167
Yang K.D., Mizobuchi T., Kharbanda S.M., Datta R., Huberman E., Kufe D.W., Stone R.M. (1994) All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line. Blood 83:490–496
Bertolaso L., Gibellini D., Secchiero P., Previati M., Falgione D., Visani G., Rizzoli R., Capitani S., Zauli G. (1998) Accumulation of catalytically active PKC-zeta into the nucleus of HL-60 cell line plays a key role in the induction of granulocytic differentiation mediated by all-trans retinoic acid. Br. J. Haematol. 100:541–549
Kikkawa U., Takai Y., Tanaka Y., Miyake R., Nishizuka Y. (1983) Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J. Biol. Chem. 258:11442–11445
Shen Z.X., Chen G.Q., Ni J.H., Li X.S., Xiong S.M., Qiu Q.Y., Zhu J., Tang W., Sun G.L., Yang K.Q., Chen Y., Zhou L., Fang Z.W., Wang Y.T., Ma J., Zhang P., Zhang T.D., Chen S.J., Chen Z., Wang Z.Y. (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): □ Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89:3354–3360
Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., Warrell Jr. R.P. (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339:1341–1348
Hannon G.J. (2002) RNA interference. Nature 418:244–251
Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498
Castanotto D., Li H., Rossi J.J. (2002) Functional siRNA expression from transfected PCR products. RNA 8:1454–1460
Gou D., Jin N., Liu L. (2003) Gene silencing in mammalian cells by PCR-based short hairpin RNA. FEBS Lett. 548:113–118
Zheng L., Liu J., Batalov S., Zhou D., Orth A., Ding S., Schultz P.G. (2004) An approach to genome wide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 101:135–140
Valverde M.A., Parker M.G. (2002) Classical and novel steroid actions: a unified but complex view. Trends Biochem. Sci. 27:172–173
Liu T.X., Zhang J.W., Tao J., Zhang R.B., Zhang Q.H., Zhao C.J., Tong J.H., Lanotte M., Waxman S., Chen S.J., Mao M., Hu G.X., Zhu L., Chen Z. (2000) Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 96:1496–1504
Radominska-Pandya A., Chen G., Czernik P.J., Little J.M., Samokyszyn V.M., Carter C.A., Nowak G. (2000) Direct interaction of all-trans-retinoic acid with protein kinase C (PKC). J. Biol. Chem. 275:22324–22330
Jing Y., Dai J., Chalmers-Redman R.M., Tatton W.G., Waxman S. (1999) Arsenic Trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94:2102–2111
Cai X., Shen Y.L., Zhu Q., Jia P.M., Yu Y., Zhou L., Huang Y., Zhang J.W., Xiong S.M., Chen S.J., Wang Z.Y., Chen Z., Chen G.Q. (2000) Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 14:262–270
Jing Y., Wang L., Xia L., Chen G.Q., Chen Z., Miller W.H., Waxman S. (2001) Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97:264–269
Andre C., Guillemin M.C., Zhu J. (1996) The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. Exp. Cell Res. 229:253–260
Leid M.P., Kastner R., Lyons H. (1992) Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377–395
Kliewer S.A., Umesono K., Mangelsdorf D.J., Evans R.M. (1992) Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355:446–449
Gery S., Park D.J., Vuong P.T., Chih D.Y., Lemp N., Koeffler H.P. (2004) Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes. Blood 104:3911–3917
Tenen D.G., Hromas R., Licht J.D., Zhang D.E. (1997) Transcription factors, normal myeloid development, and leukemia. Blood 90:489–519
Ubeda M., Wang X.Z., Zinszner H., Wu I., Habener J.F., Ron D. (1996) Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Mol. Cell Biol. 16:1479–1489
Acknowledgements
This work was supported partially by the National Natural Science Foundation of China (Nos. 30471430 and 30170812) and National Key Basic Research (973) Project (No. 2002CB512900).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, S., Shen, Q., Mao, WG. et al. JWA, a novel signaling molecule, involved in all-trans retinoic acid induced differentiation of HL-60 cells. J Biomed Sci 13, 357–371 (2006). https://doi.org/10.1007/s11373-005-9068-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11373-005-9068-0